Market Cap 481.86B
Revenue (ttm) 88.82B
Net Income (ttm) 14.07B
EPS (ttm) N/A
PE Ratio 18.88
Forward PE 18.03
Profit Margin 15.84%
Debt to Equity Ratio 0.50
Volume 14,690,800
Avg Vol 8,676,856
Day's Range N/A - N/A
Shares Out 2.41B
Stochastic %K 95%
Beta 0.38
Analysts Strong Sell
Price Target $203.50

Company Profile

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 732 524 0400
Website: www.jnj.com
Address:
One Johnson & Johnson Plaza, New Brunswick, United States
Peaceouty
Peaceouty Nov. 20 at 6:34 AM
$CANF Has more buns in the oven than you think! This’s a HUGE deal imo. Namodenoson is also currently being evaluated in a phase 3 liver cancer trial. FDA fast track and Orphan drug designation. 👊🏻 Company has a cash burn rate of 1M a month and a current market cap of 5 mill. Efficacy is basically already proven in the hard to treat cases. $SPY $XBI $QQQ $JNJ https://ca.finance.yahoo.com/news/fite-reports-h1-2025-financial-124700966.html
0 · Reply
bdrd
bdrd Nov. 19 at 10:31 PM
$JNJ $210 next
0 · Reply
HedgeAlerts
HedgeAlerts Nov. 19 at 9:17 PM
Hedge Alert Live - Protect Your Portfolio Contract: $JNJ $200.00 Put · NOV 28, 2025 Exp Entry Price: $1.70 - $2.08 Exit Price Target: $2.29 Profit Margin: +35% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com
0 · Reply
Wenwenwenwenwenwen
Wenwenwenwenwenwen Nov. 19 at 9:01 PM
$JNJ aged well😊 now keep pumping…
0 · Reply
Iightning
Iightning Nov. 19 at 8:47 PM
1ightning® Options Trade Alert (Actionable) | Buy $JNJ Dec 5 $200 Call | Enter: $2.82 Exit: $4.00 | Profit: 41.81% ROI | https://1ightning.com
0 · Reply
Wenwenwenwenwenwen
Wenwenwenwenwenwen Nov. 19 at 6:26 PM
$JNJ keep it pumping….harder…harder!
1 · Reply
RD008
RD008 Nov. 19 at 5:24 PM
$NVAX Somebody pls acquire NOVAVAX $JNJ $PFE
1 · Reply
Wenwenwenwenwenwen
Wenwenwenwenwenwen Nov. 19 at 4:47 PM
$JNJ whys this pumping?
1 · Reply
JFDI
JFDI Nov. 19 at 3:11 PM
0 · Reply
theoptionscoach
theoptionscoach Nov. 19 at 1:50 PM
$SPY $QQQ $NVDA $JNJ $IWM Good morning from theoptionscoach.net https://theoptionscoach.net/p/pre-market-nov-19-2025
0 · Reply
Latest News on JNJ
Johnson & Johnson to Buy Halda Therapeutics For $3.05 Billion

Nov 17, 2025, 8:29 AM EST - 2 days ago

Johnson & Johnson to Buy Halda Therapeutics For $3.05 Billion


Halda Therapeutics Announces Acquisition by Johnson & Johnson

Nov 17, 2025, 8:15 AM EST - 2 days ago

Halda Therapeutics Announces Acquisition by Johnson & Johnson


Johnson & Johnson: Dividends Don't Lie

Nov 7, 2025, 5:40 AM EST - 12 days ago

Johnson & Johnson: Dividends Don't Lie


Cramer's Mad Dash: Johnson & Johnson

Nov 6, 2025, 9:54 AM EST - 13 days ago

Cramer's Mad Dash: Johnson & Johnson


US FDA expands use of J&J's Caplyta as add-on depression drug

Nov 6, 2025, 7:34 AM EST - 13 days ago

US FDA expands use of J&J's Caplyta as add-on depression drug


Best Dividend Aristocrats For November 2025

Nov 1, 2025, 10:25 AM EDT - 18 days ago

Best Dividend Aristocrats For November 2025

ABBV ABT ADM ADP AMCR AOS ATO


Best Dividend Kings: October 2025

Oct 29, 2025, 5:11 AM EDT - 21 days ago

Best Dividend Kings: October 2025

ABBV ABM ABT ADM ADP AWR BDX


J&J Stock Can Fall

Oct 28, 2025, 9:25 AM EDT - 22 days ago

J&J Stock Can Fall


Johnson & Johnson Stock To $134?

Oct 22, 2025, 2:00 PM EDT - 4 weeks ago

Johnson & Johnson Stock To $134?


Johnson & Johnson (JNJ) Q3 2025 Earnings Call Transcript

Oct 14, 2025, 12:36 PM EDT - 5 weeks ago

Johnson & Johnson (JNJ) Q3 2025 Earnings Call Transcript


Peaceouty
Peaceouty Nov. 20 at 6:34 AM
$CANF Has more buns in the oven than you think! This’s a HUGE deal imo. Namodenoson is also currently being evaluated in a phase 3 liver cancer trial. FDA fast track and Orphan drug designation. 👊🏻 Company has a cash burn rate of 1M a month and a current market cap of 5 mill. Efficacy is basically already proven in the hard to treat cases. $SPY $XBI $QQQ $JNJ https://ca.finance.yahoo.com/news/fite-reports-h1-2025-financial-124700966.html
0 · Reply
bdrd
bdrd Nov. 19 at 10:31 PM
$JNJ $210 next
0 · Reply
HedgeAlerts
HedgeAlerts Nov. 19 at 9:17 PM
Hedge Alert Live - Protect Your Portfolio Contract: $JNJ $200.00 Put · NOV 28, 2025 Exp Entry Price: $1.70 - $2.08 Exit Price Target: $2.29 Profit Margin: +35% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com
0 · Reply
Wenwenwenwenwenwen
Wenwenwenwenwenwen Nov. 19 at 9:01 PM
$JNJ aged well😊 now keep pumping…
0 · Reply
Iightning
Iightning Nov. 19 at 8:47 PM
1ightning® Options Trade Alert (Actionable) | Buy $JNJ Dec 5 $200 Call | Enter: $2.82 Exit: $4.00 | Profit: 41.81% ROI | https://1ightning.com
0 · Reply
Wenwenwenwenwenwen
Wenwenwenwenwenwen Nov. 19 at 6:26 PM
$JNJ keep it pumping….harder…harder!
1 · Reply
RD008
RD008 Nov. 19 at 5:24 PM
$NVAX Somebody pls acquire NOVAVAX $JNJ $PFE
1 · Reply
Wenwenwenwenwenwen
Wenwenwenwenwenwen Nov. 19 at 4:47 PM
$JNJ whys this pumping?
1 · Reply
JFDI
JFDI Nov. 19 at 3:11 PM
0 · Reply
theoptionscoach
theoptionscoach Nov. 19 at 1:50 PM
$SPY $QQQ $NVDA $JNJ $IWM Good morning from theoptionscoach.net https://theoptionscoach.net/p/pre-market-nov-19-2025
0 · Reply
Iightning
Iightning Nov. 19 at 5:19 AM
1ightning® Options Trade Alert (Actionable) | Buy $JNJ Dec 5 $200 Call | Enter: $2.82 Exit: $4.00 | Profit: 41.81% ROI | https://1ightning.com
0 · Reply
HedgeAlerts
HedgeAlerts Nov. 19 at 3:25 AM
Hedge Alert Live - Protect Your Portfolio Contract: $JNJ $200.00 Put · NOV 28, 2025 Exp Entry Price: $3.13 - $3.25 Exit Price Target: $5.45 Profit Margin: +74% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com
0 · Reply
HedgeAlerts
HedgeAlerts Nov. 18 at 10:14 PM
Hedge Alert Live - Protect Your Portfolio Contract: $JNJ $200.00 Put · NOV 28, 2025 Exp Entry Price: $3.13 - $3.25 Exit Price Target: $5.45 Profit Margin: +74% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com
0 · Reply
Iightning
Iightning Nov. 18 at 9:14 PM
1ightning® Options Trade Alert (Actionable) | Buy $JNJ Nov 28 $195 Call | Enter: $2.21 Exit: $3.14 | Profit: 42.31% ROI | https://1ightning.com
0 · Reply
Mangokitty83
Mangokitty83 Nov. 18 at 8:11 PM
0 · Reply
Seansigma
Seansigma Nov. 18 at 5:28 PM
$JNJ short this.....merry Xmas
1 · Reply
ZacksResearch
ZacksResearch Nov. 18 at 4:25 PM
$JNJ on a buying spree — what does the Halda Therapeutics deal mean for investors? 💰 J&J is acquiring Halda for $3.05B, adding promising RIPTAC platform tech to bolster its oncology pipeline, especially in prostate cancer. The acquisition is expected to dilute adjusted EPS by approximately 15 cents in 2026. 📈 Discover the implications for JNJ's future here 👉 https://www.zacks.com/stock/news/2792619/jj-joins-pharma-ma-bandwagon-to-buy-cancer-biotech-for-305b?cid=sm-stocktwits-2-2792619-body-21436&ADID=SYND_STOCKTWITS_TWEET_2_2792619_BODY_21436
0 · Reply
ZacksResearch
ZacksResearch Nov. 18 at 3:25 PM
M&A heat is officially back in pharma 👀 $JNJ is dropping $3.05B on Halda to lock in targeted oral cancer therapies and bulk up its prostate cancer pipeline — a clear swing as sector dealmaking ramps up. Full breakdown on the move here 👉 https://www.zacks.com/stock/news/2792619/jj-joins-pharma-ma-bandwagon-to-buy-cancer-biotech-for-305b?cid=sm-stocktwits-2-2792619-teaser-21426&ADID=SYND_STOCKTWITS_TWEET_2_2792619_TEASER_21426
0 · Reply
PickAlpha
PickAlpha Nov. 18 at 1:14 PM
2/3: Johnson & Johnson to acquire private cancer-drug developer Halda Therapeutics for $3.05 billion in cash $JNJ $XLV $XBI
0 · Reply
ChartMill
ChartMill Nov. 18 at 12:48 PM
Johnson & Johnson ( $JNJ | +1.86%) grabbed attention with a $3.05 billion all-cash acquisition of privately held Halda Therapeutics, a biotech specializing in cancer treatments. Its lead candidate, HLD-0915, is targeting prostate cancer and is still early in clinical development. The market liked the deal. J&J shares rose 1.9%, making it the day’s top performer in the Dow.
0 · Reply
Iightning
Iightning Nov. 18 at 8:17 AM
1ightning® Options Trade Alert (Actionable) | Buy $JNJ Nov 28 $195 Call | Enter: $2.21 Exit: $3.14 | Profit: 42.31% ROI | https://1ightning.com
0 · Reply
danaos
danaos Nov. 18 at 12:40 AM
$JNJ Overweight
0 · Reply